Found: 7
Select item for more details and to access through your institution.
Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Targeting proliferative retinopathy: Arginase 1 limits vitreoretinal neovascularization and promotes angiogenic repair.
- Published in:
- Cell Death & Disease, 2022, v. 13, n. 8, p. 1, doi. 10.1038/s41419-022-05196-8
- By:
- Publication type:
- Article
Endogenous arginase 2 as a potential biomarker for PEGylated arginase 1 treatment in xenograft models of squamous cell lung carcinoma.
- Published in:
- Oncogenesis, 2019, v. 8, n. 3, p. 1, doi. 10.1038/s41389-019-0128-0
- By:
- Publication type:
- Article
Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC).
- Published in:
- Cancer Cell International, 2009, v. 9, p. 1, doi. 10.1186/1475-2867-9-9
- By:
- Publication type:
- Article
Pegylated Recombinant Human Arginase 1 Induces Autophagy and Apoptosis via the ROS-Activated AKT/mTOR Pathway in Bladder Cancer Cells.
- Published in:
- Oxidative Medicine & Cellular Longevity, 2021, p. 1, doi. 10.1155/2021/5510663
- By:
- Publication type:
- Article
Inhibition of ornithine decarboxylase 1 facilitates pegylated arginase treatment in lung adenocarcinoma xenograft models.
- Published in:
- Oncology Reports, 2018, v. 40, n. 4, p. 1994, doi. 10.3892/or.2018.6598
- By:
- Publication type:
- Article
Recombinant human arginase induces apoptosis through oxidative stress and cell cycle arrest in small cell lung cancer.
- Published in:
- Cancer Science, 2018, v. 109, n. 11, p. 3471, doi. 10.1111/cas.13782
- By:
- Publication type:
- Article